Description
Springer Neuroendocrine Tumors in Real Life From Practice to Knowledge 1st Editon 2018 Hardbound by Annamaria Colao, Antongiulio Faggiano, Wouter de Herder
This book on neuroendocrine tumors (NETs) aims to present, in a clear and innovative manner, a broad topic that is still unevenly and in some respects poorly delineated. The novel feature is the nature of the focus on the principles of prognosis, diagnosis, and therapy, which are outlined on the basis of well-defined clinical scenarios described with the aid of high-quality images and illustrations. The salient observations to emerge from the reported clinical cases are clearly summarized, taking into account evidence from the literature and the available guidelines. All of the significant prognostic factors – histopathological, molecular, and imaging – and current diagnostic and therapeutic strategies for the major NETs (stomach, pancreas, ileum, appendix, bronchus) are covered. In addition, in the introductory part of the book the reader will find information on basic aspects including epidemiology, classification, and underlying biological mechanisms. Neuroendocrine Tumors in Real Life will be of interest to all specialists involved in the management of NETs; it will provide the experienced with important updates and equip trainees and students with a firm understanding of key concepts. Part I General Remarks: Epidemiology of NET (by site of tumour and by geographical area).- Pathological classification (GEP, TNET and rare forms).-Biology of NET (oncogenes, tumor suppressor genes, epigenetics).- Part II Clinical Cases and Their Implications (from clinical practice to guidelines): Prognostic factors: TNM.- Grading (Ki67 score).- Molecular pathway - somatostatin receptors.- Molecular pathway - oncogene (mTOR).- Molecular pathway - tumor suppressor gene (MEN1).- Nuclear medicine imaging (FDG-PET).- Nuclear medicine imaging (Octreoscan / gallium PET).- Diagnosis: Tumor detection in syndromic NET (carcinoid syndrome).- Tumor detection in syndromic NET (ZES).- Tumor detection in syndromic NET (hypoglycemic hyperinsulinemic syndrome).- Tumor detection in incidentally detected non-functioning NET.- Tumor staging (stomach/duodenum, colon/rectum).- Tumor staging (bronchi).- Tumor staging (ileum).- Tumor staging (pancreas).- Therapy: Locoregional disease (stomach).- Locoregional disease (pancreas).- Locoregional disease (ileum).- Locoregional disease (appendix).- Locoregional disease (bronchi).- Metastatic disease (stomach).- Metastatic disease (pancreas).- Metastatic disease (ileum).- Metastatic disease (appendix).- Metastatic disease (bronchi.- Metastatic disease with unknown primary tumour.